Calendar Tilray Brands, Inc.

Equities

TLRY

US88688T2096

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 04:00:00 2026-02-06 pm EST			5-day change	1st Jan Change
7.580 ^USD	+7.52%		+1.61%	-16.06%

Jan. 22	Tilray Medical Strengthens Italian Market Presence with the Launch of Tilray Medical Italia and Expanded Medical Cannabis Portfolio	CI
Jan. 22	Tilray Solidifies Italian Market Presence With Launch of Tilray Medical Italia	MT

Chart calendar Tilray Brands, Inc.

f30c.o8yOlMjInnaNz8XqrrQuYofvo3LnMqor_mWPpziYKFQ.74j-46u6yD_ltoSs7NFUKvCr4DqsfNx0tArs0nGsewvoodnT_v_tBs-jiA~b983aecc359a3bb552d44e74e8c03064

Upcoming events on Tilray Brands, Inc.

2026-04-13	Q3 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
2026-07-28	Q4 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
2026-09-30	Q1 2027 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
2027-01-10	Q2 2027 Earnings Release (Projected)	Add to your calendar Google Apple ICS format

Past events on Tilray Brands, Inc.

2026-01-08	Q2 2026 Earnings Call
2026-01-08	Q2 2026 Earnings Release
2025-11-18	Annual General Meeting
2025-10-09	Q1 2026 Earnings Call
2025-10-09	Q1 2026 Earnings Release
2025-07-28	Q4 2025 Earnings Call
2025-07-28	Q4 2025 Earnings Release
2025-06-09	Extraordinary Shareholders Meeting
2025-06-03	TD Cowen Future of the Consumer Conference
2025-04-08	Q3 2025 Earnings Call
2025-04-08	Q3 2025 Earnings Release
2025-01-10	Q2 2025 Earnings Call
2025-01-10	Q2 2025 Earnings Release
2024-12-19	Annual General Meeting
2024-10-10	Q1 2025 Earnings Call
2024-10-10	Q1 2025 Earnings Release
2024-08-14	CG Growth Conference
2024-07-29	Q4 2024 Earnings Call
2024-07-29	Q4 2024 Earnings Release
2024-04-09	Q3 2024 Earnings Call

Annual results

Fiscal Period	May	2023	2024	2025	2026	2027	2028
Net sales Million USD	Released Forecast Spread	627 598 4.8%	789 783 0.74%	821 830 -1.09%	866	906	941
EBITDA Million USD	Released Forecast Spread	61,5 59,3 3.76%	60,5 59,7 1.23%	55,0 51,6 6.65%	60,6	79,6	99,2
EBIT Million USD	Released Forecast Spread	-108 -126 14.27%	-175 -171 -2.01%	-2 283 -851 -168.16%	-23,2	-13,7	0,00
Earnings before Tax (EBT) Million USD	Released Forecast Spread	-1 450 -1 071 -35.36%	-249 -210 -18.48%	-2 302 -578 -298.61%	-64,8	-35,3	-17,1
Net income Million USD	Released Forecast Spread	-1 443 -1 212 -19.1%	-222 -217 -2.28%	-2 181 -800 -172.7%	-61,6	-32,0	-10,4
EPS USD	Released Forecast Spread	-23,5 -20,1 -17.09%	-3,30 -3,23 -2.21%	-24,6 -8,92 -175.89%	-0,58	-0,29	0,03
Announcement Date		26/07/23	29/07/24	28/07/25	-

Quarterly results

Fiscal Period	November	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4	2027 Q1	2027 Q2	2027 Q3	2027 Q4
Net sales Million USD	Released Forecast Spread	230 227 1.14%	200 221 -9.42%	211 216 -2.49%	186 210 -11.44%	225 233 -3.75%	210 206 1.82%	218 211 3.01%	201	239	219	230	212	245
EBITDA Million USD	Released Forecast Spread	29,5 28,5 3.53%	9,33 13,4 -30.47%	9,02 12,3 -26.69%	9,04 9,52 -5.08%	27,6 23,7 16.69%	10,2 10,3 -1.05%	8,37 8,13 2.87%	10,3	32,5	15,0	16,6	16,4	30,5
EBIT Million USD	Released Forecast Spread	-16,5 -12,7 -30.38%	-36,6 -18,5 -97.85%	-42,2 -22,5 -87.74%	-760 -31,4 -2320.16%	-1 444	2,09 -30,1 106.96%	-22,3 -12,7 -75.43%	-14,5	6,37	-5,27	-7,95	-3,31	6,83
Earnings before Tax (EBT) Million USD	Released Forecast Spread	-43,0 -21,3 -101.9%	-33,8 -30,0 -12.58%	-83,2 -36,7 -126.79%	-792 -43,5 -1721.45%	-1 393 -34,6 -3926.12%	-0,77 -37,6 97.94%	-40,0 -22,5 -77.61%	-20,3	-1,32	-9,99	-15,2	-7,68	-0,62
Net income Million USD	Released Forecast Spread	-15,4 -20,4 24.71%	-34,7 -28,6 -21.34%	-85,3 -35,0 -143.8%	-794 -37,2 -2033.16%	-1 268 -23,3 -5341.61%	1,51 -31,3 104.83%	-43,5 -17,2 -152.47%	-15,7	0,61	-9,06	-14,1	-6,94	-0,61
EPS USD	Released Forecast Spread	-0,40 -0,23 -71.43%	-0,40 -0,50 20%	-1,00 -0,40 -150%	-8,70 -0,40 -2075%	-13,0 -0,27 -4774.94%	0,00 -0,30 -	-0,41 -0,14 -192.86%	-0,14	0,00	-0,08	-0,12	-0,06	-0,01
Announcement Date		29/07/24	10/10/24	10/01/25	08/04/25	28/07/25	09/10/25	08/01/26	-	-	-	-	-	-

Upcoming sector events for Tilray Brands, Inc.

2026-02-08	PFIZER LIMITED	Q3 2026 Earnings Release	Add to your calendar Google Apple ICS format
2026-02-08	AUROBINDO PHARMA	Q3 2026 Earnings Release	Add to your calendar Google Apple ICS format
2026-02-08	EISAI CO., LTD.	Q3 2025 Earnings Release	Add to your calendar Google Apple ICS format
2026-02-08	NIPPON SHINYAKU CO., LTD.	Q3 2025 Earnings Release	Add to your calendar Google Apple ICS format
2026-02-08	GLAXOSMITHKLINE PHARMACEUTICALS LIMITED	Q3 2026 Earnings Release	Add to your calendar Google Apple ICS format
2026-02-08	SUPRIYA LIFESCIENCE LIMITED	Q3 2026 Earnings Release	Add to your calendar Google Apple ICS format
2026-02-08	NEULAND LABORATORIES LIMITED	Q3 2026 Earnings Release	Add to your calendar Google Apple ICS format
2026-02-08	AARTI PHARMALABS LIMITED	Q3 2026 Earnings Release	Add to your calendar Google Apple ICS format
2026-02-08	SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED	Q3 2026 Earnings Release	Add to your calendar Google Apple ICS format
2026-02-08	ST PHARM CO.,LTD.	Q4 2025 Earnings Release	Add to your calendar Google Apple ICS format

More events

Past sector events for Tilray Brands, Inc.

2026-02-06	JEENA SIKHO LIFECARE LIMITED	Q3 2026 Earnings Release
2026-02-06	SUDEEP PHARMA LIMITED	Q3 2026 Earnings Release
2026-02-06	ROIVANT SCIENCES LTD.	Q3 2025 Earnings Release
2026-02-06	SHILPA MEDICARE LIMITED	Q3 2026 Earnings Release
2026-02-06	JUBILANT PHARMOVA LIMITED	Q3 2026 Earnings Release
2026-02-05	TORII PHARMACEUTICAL CO., LTD.	Q4 2025 Earnings Release (Projected)
2026-02-05	KAKEN PHARMACEUTICAL CO., LTD.	Q3 2025 Earnings Release
2026-02-05	MOCHIDA PHARMACEUTICAL CO., LTD.	Q3 2025 Earnings Release
2026-02-05	TSUMURA & CO.	Q3 2025 Earnings Release
2026-02-05	SAI LIFE SCIENCES LIMITED	Q3 2026 Earnings Release